Gang Ma

Gang Ma

Auto-generated profile, based on publicly available information

Gang Ma

Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tianjin, 300060, China.

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
MZMengmeng Zhang
Mengmeng Zhang
FCFenglin Cai
Fenglin Cai
JGJiamei Guo
Jiamei Guo
SLSiya Liu
Siya Liu
GMGang Ma
Gang Ma
JDJingyu Deng
Jingyu Deng
The contributions of aberrantly expressed metabolic enzymes to gastric cancer (GC) initiation and progression have been widely appreciated in recent years. Acetyl-CoA acetyltransferase 2 (ACAT2) is one member of the acetyl- CoA thiolase family. Previous studies demonstrated that ACAT2 either promotes or suppresses tumor progression in different conditions. However, the function and mechanisms of ACAT2 in GC remain unknown. We found that the expression of this enzyme was significantly increased in GC tissues compared with normal counterparts, which prompted us to further investigate the roles of this protein in GC biology. In vitro functional studies showed that ACAT2 knockdown markedly halted the proliferation and the motility of GC cells; these functions favoring malignant phenotypes of GC cells were further validated in animal experiments. Mechanistically, ACAT2 depletion significantly reduced the transcription of SETD7, which is a histone methyltransferase and plays critical roles in GC cells. We found that the pro-tumoral functions of ACAT2 were largely dependent on SETD7. Moreover, SETD7 decreased the ubiquitination level of Yes-associated protein 1 (YAP1), thereby protecting YAP1 from proteasome degradation. Increased YAP1 protein expression remarkably activated the YAP1/TAZ-TEAD1 signaling pathway, which further boosted the malignant phenotypes in GC cells. In conclusion, these findings highlight the pro-tumoral functions and molecular underpinnings of ACAT2 in GC cells, and suggest that ACAT2 could be a promising target in GC treatment.

5 September 2022 in Polymer Testing
Verified
Journal Article
Open access
YXYa Xu
Ya Xu
RZRu Zhou
Ru Zhou
GMGang Ma
Gang Ma
LDLisha Deng
Lisha Deng
HLHuimin Liu
Huimin Liu
JJJuncheng Jiang
Juncheng Jiang

16 December 2022 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
GMGang Ma
Gang Ma
ZZZhenzhen Zhao
Zhenzhen Zhao
YQYang Qu
Yang Qu
FCFenglin Cai
Fenglin Cai
SLSiya Liu
Siya Liu
JDJingyu Deng
Jingyu Deng
Whereas cysteine dioxygenase 1 (CDO1) expression is lost due to its hypermethylated promoter across a range of cancer types including gastric cancer (GC), its functions and molecular underpinnings remain largely unknown. Here we demonstrate that reduced CDO1 expression is indicative of unfavorable prognosis in patients with GC. CDO1 overexpression in GC cells markedly inhibits cellular proliferation in vitro and in vivo. Mechanistically, CDO1 exerts this cytostatic effect via increasing oxidative stress and thus activating integrated stress response (ISR) in GC cells. High throughput screening (HTS) of antioxidants library identifies that Engeletin, a flavanonol glycoside, blunts oxidative stress and the ISR to relieve the inhibitory effect of CDO1 on the proliferation in GC cells. Additionally, genetic disruption or pharmaceutical inhibition of the ISR boosts the growth in the GC cells with CDO1 expression. Our data uncover the molecular mechanisms underlying the cytostatic function of CDO1 in the proliferation of GC cells.

29 June 2023 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YZYi Zeng
Yi Zeng
GMGang Ma
Gang Ma
FCFenglin Cai
Fenglin Cai
PWPengliang Wang
Pengliang Wang
HLHan Liang
Han Liang
YLYong Liu
Yong Liu
Protein lysine methyltransferase SET and MYND domain-containing 3 (SMYD3) is aberrantly expressed in various cancer settings. The mechanisms that SMYD3 activates the expression of critical pro-tumoral genes in an H3K4me3-dependent manner have been well described in previous reports. Besides H3K4me3, H4K20me3 is another catalytic product of SMYD3, however it is a transcriptionally repressive hallmark. Since it is not clear that how SMYD3-elicited transcriptionally repressive program functions in cancer, we used gastric cancer (GC) as a model to investigate the roles of SMYD3-H4K20me3. Herein, online bioinformatics tools, quantitative PCR, western blotting and immunohistochemistry assays demonstrated that SMYD3 expression was markedly increased in GC tissues from our institutional and The Cancer Genome Atlas (TCGA) cohort. Additionally, aberrantly increased SMYD3 expression was closely associated with aggressive clinical characteristics and poor prognosis. Depletion of endogenous SMYD3 expression using shRNAs significantly attenuates the proliferation in GC cells and Akt signaling pathway in vitro and in vivo. Mechanistically, chromatin immunoprecipitation (ChIP) assay showed that SMYD3 epigenetically repressed the expression of epithelial membrane protein 1 (EMP1) in an H4K20me3-dependent manner. Gain-of-function and rescue experiments validated that EMP1 inhibited the propagation of GC cells and reduced p-Akt (S473) level. Based on these data, pharmaceutical inhibition of SMYD3 activity using the small inhibitor BCI-121 deactivated Akt signaling pathway in GC cells and further impaired the cellular viability in vitro and in vivo. Together, these results demonstrate that SMYD3 promotes the proliferation in GC cells and may be a valid target for therapeutic intervention of patients with GC.

6 January 2024 in British Journal of Cancer
Verified
Journal Article
Closed access
PDF file
FCFenglin Cai
Fenglin Cai
XYXiuding Yang
Xiuding Yang
GMGang Ma
Gang Ma
PWPengliang Wang
Pengliang Wang
MZMengmeng Zhang
Mengmeng Zhang
JDJingyu Deng
Jingyu Deng

11 April 2023 in Experimental Cell Research
Verified
Journal Article
Closed access
GMGang Ma
Gang Ma
YSYi Sun
Yi Sun
FCFenglin Cai
Fenglin Cai
MZMengmeng Zhang
Mengmeng Zhang
HLHan Liang
Han Liang
LZLi Zhang
Li Zhang